The Motley Fool··Prosper Junior BakinyDexCom Positioned as Hidden Beneficiary in GLP-1 Drug Expansion
DexCom benefits from GLP-1 drug expansion as CGM devices are increasingly prescribed together, unlocking significant untapped patient markets and complementary revenue opportunities.
DXCMhealthcare stocksmedical devices